Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes - Wikidata - wikimedia - TriplyDB

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

http://www.wikidata.org/entity/Q33691211

about

FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancer Signaling cross-talk in the resistance to HER family receptor targeted therapy A perspective on anti-EGFR therapies targeting triple-negative breast cancer Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon.Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity.Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.ZD6474 coerces breast cancer for an apoptotic journey Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations Epitope mapping of epidermal growth factor receptor (EGFR) monoclonal antibody and induction of growth-inhibitory polyclonal antibodies by vaccination with EGFR mimotope.Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer.A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.The biology of progesterone receptor in the normal mammary gland and in breast cancer Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas.Biomarkers characterization of circulating tumour cells in breast cancer patients Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function.EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.EGFR and HER2 signaling in breast cancer brain metastasis.X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer The identification and characterization of breast cancer CTCs competent for brain metastasis.The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer.Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging.The relevance of the intrinsic subtype to the clinicopathological features and biomarkers in Japanese breast cancer patients.

P2860

Q24296333-79AE4CAC-449E-4496-BAC0-56BC34C318FF Q27025863-BCE65C07-518E-45E8-A48D-0169AC0FD538 Q27027778-6C7CADE8-4E39-4B43-8FDE-C3CCB6C2CAF2 Q28069867-FBFEAD30-AF22-4CA6-A493-B2276D55DDD5 Q28077637-650B3CDF-A295-4D9B-8977-BFF953DCEBF4 Q28087571-E4D86C37-08A1-4A4F-AC30-F32E4B389489 Q28534358-577B692A-5C38-43D6-BD11-F890377C81F1 Q33899089-BCE1BE45-3978-4F41-9A17-D030ABD2BA5E Q34156903-68840C75-2D44-4195-B36E-8973C2542384 Q34240076-54C8D0A0-41BB-45FD-8CCF-C5950CDC6920 Q34275213-3176ABC8-1E29-41ED-8320-3AA20D163B05 Q34377637-0D1CEA82-5C1A-4196-9A2C-4913CCF8C78D Q34440490-9027B003-DE6C-4831-A8D4-FEDAF478CE27 Q34562257-74289DDE-D341-409D-BED3-E21871F4D972 Q34686900-E3552213-1BC7-4F91-8069-BD9DC5C55A86 Q35077775-C2D4B9EC-1B7C-4A69-A488-4BF33213E52E Q35214496-EACB7DE2-4777-4945-8897-F22333CF4B3D Q35593599-CFC43206-B20F-4589-9F74-9DE6A54A6DC0 Q35624196-6BFF628D-CE33-4B3F-8543-3D565989E3DF Q35771300-650BC3E0-1737-4B2E-A1E9-AAE72538FBBE Q35784682-B550680C-3DA4-45BD-AF12-BB6060C543FE Q35866971-C622C623-78A2-4F84-84E7-FB7D293C7345 Q35868802-F7FD3D29-E2EA-42AC-9089-6B09C3BD5F9A Q35888553-90BE1318-B088-451A-AFED-24D3E9C40858 Q35990886-FCFB62B4-4E87-489E-AFB8-2B3B491D45EB Q36026041-4DB7B7EC-9804-4FAE-BA0C-C656A685E0F1 Q36245346-A77A4357-948D-4497-A1F9-F92BCF448A6E Q36361958-FD83237F-7365-45CA-8B90-F6B32E722E73 Q36421921-F4A3D90B-6E15-473A-AB37-9E8A560D958C Q36442340-C7173709-52E9-4195-B244-531923B5B42C Q36539643-DA5A7E9F-51A9-4C46-AAA9-36E56C09B656 Q36665258-0A5579A5-28EE-4D4B-ACC0-69F381943F81 Q36733618-44A53927-D1FF-4B39-B0A1-5582A21698B6 Q36751784-BFF01FD8-C354-4CEA-8F0D-A9F5677025AB Q36821159-2A4BDA43-E78A-4866-A121-7EA18BDCA648 Q37107395-8F470295-D98C-4084-B41C-E2DB045769AD Q37394096-006FAF64-087E-40F0-9348-FDC22EC61E2D Q37514113-4C9C8FFD-123D-4F80-A31D-17C582066A2E Q37541860-806415C1-B3C3-4C05-9682-360D6FA2F41B Q37554308-B33D1FB5-B50D-434C-8867-F41601C70882

P2860

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

http://www.wikidata.org/entity/Q33691211

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Epidermal growth factor recept ...... henotype and clinical outcomes

@ast

Epidermal growth factor recept ...... henotype and clinical outcomes

@en

type

label

Epidermal growth factor recept ...... henotype and clinical outcomes

@ast

Epidermal growth factor recept ...... henotype and clinical outcomes

@en

prefLabel

Epidermal growth factor recept ...... henotype and clinical outcomes

@ast

Epidermal growth factor recept ...... henotype and clinical outcomes

@en

P1433

Q33691211-74F45223-DB6C-48BE-82A8-A5277E2B6429

P1476

Q33691211-DB57106C-501F-4758-9ADF-9A4A664500AD

P2093

Q33691211-018C285C-4DD0-4914-BEFE-CD40F0AF174E

Q33691211-0A720BCD-CD9D-4C78-8D99-1D7A302FA9DC

Q33691211-15CA6E45-90D8-45BF-9FCF-8685FF70B027

Q33691211-2CC5D619-DCE1-46E9-AC6C-0B9DFCB66427

Q33691211-720610F5-593B-4863-99E9-7DC68C8B8E65

Q33691211-7F2DD984-F3B9-47BE-9D9C-F07E443AB1FF

Q33691211-8F4B7470-7D88-41B6-9980-B2EC3B254960

P2860

Q33691211-09C7F23C-604C-4E72-9503-E93FDC9A9915

Q33691211-0A5B41EE-FEB6-4C8B-B8F9-F9A2D24072E0

Q33691211-0BB63FD3-DCC0-4708-8F32-171515EE21B7

Q33691211-11A1316A-6D5A-4CF7-96D3-A0CCEFB89E63

Q33691211-13DA5F1E-711F-4895-9512-BFA970B9E053

Q33691211-2FB19DFF-BA56-4069-A895-2C6F63C1A6F1

Q33691211-302608A0-4F4A-472D-BE27-DFCCF86BD764

Q33691211-3139C028-BC3C-4FFB-9AA4-23DFFE7BED11

Q33691211-34BB7CE3-1D12-409F-BEC4-A9BFEFB2D811

Q33691211-35D53541-2C57-4A1F-84A9-A38A772BF42C

P304

Q33691211-AF29DAF3-8700-4091-B6A1-B2EDDC8A2261

P31

Q33691211-4675A3BE-D9CF-4231-B2D5-E00E4BC9569E

P356

Q33691211-16F72DB9-7C7A-4C30-9B1E-CC4439A92D81

P407

Q33691211-8EC4E5A7-2740-4AEE-A168-0393DB68A60B

P433

Q33691211-DDFCE8F0-570A-4335-B499-8F7BE5DF3245

P478

Q33691211-04A7D41A-2513-4EB7-A9CC-DD2F798AE85C

P577

Q33691211-D5B40BE0-8B98-47D9-BA67-88617E65C9ED

P5875

Q33691211-A9D68EF6-677C-4567-9FCF-A1BF6311F38C

P698

Q33691211-D0D31C46-5D05-4DB7-B174-C8695899110E

P932

Q33691211-4E0C1DF4-CD28-4531-8D4A-D69A918D1541

P356

P1433

P1476

Epidermal growth factor recept ...... henotype and clinical outcomes

@en

P2093

C Kent Osborne

http://www.w3.org/2001/XMLSchema#string

Gary C Chamness

http://www.w3.org/2001/XMLSchema#string

Heidi L Weiss

http://www.w3.org/2001/XMLSchema#string

Mothaffar F Rimawi

http://www.w3.org/2001/XMLSchema#string

Priya B Shetty

http://www.w3.org/2001/XMLSchema#string

Rachel Schiff

http://www.w3.org/2001/XMLSchema#string

Richard M Elledge

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

Untangling the ErbB signalling network

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Molecular portraits of human breast tumours

EGF-ERBB signalling: towards the systems level

The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

P304

1234-1242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24816

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41042101

http://www.w3.org/2001/XMLSchema#string

P698

20082448

http://www.w3.org/2001/XMLSchema#string

P932

2829330

http://www.w3.org/2001/XMLSchema#string